AGM/EGMJun 18, 2026, 05:01 PM
Supernus Stockholders Elect Directors, Approve Comp & Equity Plan
AI Summary
Supernus Pharmaceuticals, Inc. held its Annual Meeting of Stockholders on June 18, 2026. Stockholders elected Frederick M. Hudson and Charles W. Newhall, III as Class I Directors. They also approved, on a non-binding basis, the compensation paid to named executive officers and ratified KPMG LLP as the independent public accounting firm for 2026. Additionally, a proposal to amend the 2021 Equity Incentive Plan to increase available shares was approved.
Key Highlights
- Frederick M. Hudson elected Class I Director with 45,058,634 votes for.
- Charles W. Newhall, III elected Class I Director with 41,743,154 votes for.
- Non-binding executive compensation approved with 45,552,633 votes for.
- KPMG LLP ratified as independent auditor with 49,882,228 votes for.
- 2021 Equity Incentive Plan amendment approved with 41,925,692 votes for.
- 58,039,721 shares of common stock outstanding and entitled to vote.
Price Impact
More from SUPN